TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
34,825
|
20,591
|
17,462 |
Financial expenses |
178
|
80
|
1 |
Earnings before taxes |
7,860
|
-5,618
|
-6,951 |
EBITDA |
7,048
|
-6,078
|
-7,081 |
Total assets |
46,190
|
35,836
|
28,215 |
Current assets |
43,702
|
32,838
|
25,233 |
Current liabilities |
33,827
|
31,632
|
22,965 |
Equity capital |
12,363
|
4,204
|
5,251 |
- share capital |
101
|
95
|
98 |
Employees (average) |
16
![]() |
16
|
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.8%
|
11.7%
|
18.6% |
Turnover per employee |
2,177
|
1,287
|
1,247 |
Profit as a percentage of turnover |
22.6%
|
-27.3%
|
-39.8% |
Return on assets (ROA) |
17.4%
|
-15.5%
|
-24.6% |
Current ratio |
129.2%
|
103.8%
|
109.9% |
Return on equity (ROE) |
63.6%
|
-133.6%
|
-132.4% |
Change turnover |
12,773
|
3,653
|
756 |
Change turnover % |
58%
|
22%
|
5% |
Chg. No. of employees |
0
|
2
|
1 |
Chg. No. of employees % |
0%
|
14%
|
8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.